Skip to main content

Advertisement

Log in

Comorbid psychopathology in adolescents and young adults treated for substance use disorders

A review

  • ORIGINAL CONTRIBUTION
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract

Objective

In a recent review, the prevalence of comorbid psychiatric disorders in non-treated adolescents and young adults with substance use disorders (SUD) in the general population was summarized. This review looks into the prevalence of psychiatric comorbidity in adolescents and young adults treated for SUD.

Method

A computerized literature search was conducted resulting in ten eligible studies.

Results

The prevalence of comorbid psychiatric disorders varied from 61% to 88%. Externalizing disorders, especially Conduct Disorder (CD), were most consistently linked to SUD in treatment seeking adolescents. Girls are distinguished by their high rate of comorbid internalizing disorders.

Conclusions

Comparison with data from community and juvenile justice studies shows an ascending trend of comorbidity rates of externalizing disorders from community to clinical and finally to juvenile justice samples. It seems that young addicts with comorbid disorders are at high risk of ending up in the juvenile justice system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abram KM, Teplin LA, McClelland, Dulcan MK (2003) Comorbid Psychiatric Disorders in Youth in Juvnile Detention. Arch Gen Psychiatry 60:1097–1108

    Article  PubMed  Google Scholar 

  2. Armstrong TD, Costello EJ (2002) Community studies on adolescent substance use abuse or dependence and psychiatric comorbidity. J Consult Clin Psychol 70:1224–1239

    Article  PubMed  Google Scholar 

  3. Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, Rothenberger A (2003) Association of ADHD and conduct disorder – brain electrical evidence for the existence of a distinct subtype. J Child Psychol Psychiatry 44:356–376

    Article  PubMed  Google Scholar 

  4. Wise BK, Cuffe SP, Fischer T (2001) Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat 21:161–165

    Article  PubMed  CAS  Google Scholar 

  5. Biederman J, Willens T, Mick E, Faraone SV, Spencer T (1998) Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 44:269–273

    Article  PubMed  CAS  Google Scholar 

  6. Biederman J, Willens T, Mick E, Faraone SV, Weber W, Curtis S, Thrornell A, Pfister K, Jetton JG, Soriano J (1997) Is ADHD a risk factor for psychoactive substance use disorders: Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36:21–29

    Article  PubMed  CAS  Google Scholar 

  7. Bucholz KK (1999) Nosology and epidemiology of addictive disorders and their comorbidity. Psychiatr Clin North Am 22:221–240

    Article  PubMed  CAS  Google Scholar 

  8. Bukstein OG, Glancy LJ, Kaminer Y (1992) Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry 31:1041–1045

    PubMed  CAS  Google Scholar 

  9. Clark DB, Parker AM, Lynch KG (1999) Psychopathology and substance-related problems during early adolescence: a survival analysis. J Clin Child Psychol 28:333–341

    Article  PubMed  CAS  Google Scholar 

  10. Clark DB, Pollock N, Bukstein OG, Mezzich AC, Bromberger JT, Donovan JE (1997) Gender and comorbid psychopathology in adolescents with alcohol dependence. J Am Acad Child Adolesc Psychiatry 36:1195–1203

    Article  PubMed  CAS  Google Scholar 

  11. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A (2003) Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60:837–844

    Article  PubMed  Google Scholar 

  12. Cottler LB, Schuckit MA, Helzer JE, Crowley T, Woody G, Nathan P, Hughes J (1995) The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend 38:59–69

    Article  PubMed  CAS  Google Scholar 

  13. Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK (1998) Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend 50:27–37

    Article  PubMed  CAS  Google Scholar 

  14. Dakof GA (2000) Understanding Gender Differences in Adolescent Drug Abuse: Issues of Comorbidity and Family Functioning. J Psychoactive Drugs 32:25–32

    PubMed  CAS  Google Scholar 

  15. Dennis ML (1998) Global appraisal of individual needs (GAIN) manual: administration, scoring and interpretation. Lighthouse Publications, Bloomington, IL

    Google Scholar 

  16. Deykin EY, Buka SL, Zeena TH (1992) Depressive illness among chemically dependent adolescents. J Am Psychiatry 149:1341–1347

    CAS  Google Scholar 

  17. Ferdinand RF, Blüm M, Verhulst FC (2001) Psychopathology in adolescence predicts substance use in young adulthood. Addiction 96:861–870

    Article  PubMed  CAS  Google Scholar 

  18. Fisckenscher A, Novins D (2003) Gender differences and conduct disorder among American Indian adolescents in substance abuse treatment. J Psychoactive Drugs 35:79–84

    PubMed  Google Scholar 

  19. Flory K, Lynam DR (2003) The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play? Clin Child Fam Psychol Rev 6:1–16

    Article  PubMed  Google Scholar 

  20. Friedman AS, Utada A (1989) A method for diagnosing and planning the treatment of adolescent drug abusers: the Adolescent Drug Abuse Diagnosis (ADAD) instrument. J Drug Educ 19:285–312

    PubMed  CAS  Google Scholar 

  21. de Graaf R, Bijl RV, Ten Have M, Beekman AT, Vollebergh WA (2004) Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord 82:461–467

    Article  PubMed  Google Scholar 

  22. Grella C.E. Hser YI, Joshi V, et al. (2001) Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 198:384–392

    Article  Google Scholar 

  23. Grilo CM, Becker DF, Fehon DC, Edell WS, McGlashan (1996) Conduct disorder, substance use disorders, and coexisting conduct and substance use disorders in adolescent inpatients. Am J Psychiatry 153:914–920

    PubMed  CAS  Google Scholar 

  24. Hannesdóttir H, Tyrfingsson T, Piha J (2001) Psychosocial functioning and psychiatric comorbidity among substance-abusing Icelandic adolescents. Nord J Psychiatry 55:43–48

    Article  PubMed  Google Scholar 

  25. Harrison PA, Fulkerson JA, Beebe TJ (1998) DSM-IV substance use disorder criteria for adolescents: a critical examination based on a statewide school survey. Am J Psychiatry 155:486–492

    PubMed  CAS  Google Scholar 

  26. Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ (2004) Family Transmission and Heritability of Externalizing Disorders: A Twin Study. Arch Gen Psychiatry 60:922–928

    Article  Google Scholar 

  27. Hovens JGFM, Cantwell DP, Kiriakos R (1994) Psychiatric comorbidity in hospitalized adolescent substance abusers. J Am Acad Child Adolesc Psychiatry 33:476–483

    PubMed  CAS  Google Scholar 

  28. Jainchill N, De Leon G, Yagelka J (1997) Ethnic differences in psychiatric disorders among adolescent substance abusers in treatment. J Psychopath Behav Assessment 19:133–148

    Article  Google Scholar 

  29. Khantzian E (1997) The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 4:231–244

    PubMed  CAS  Google Scholar 

  30. Kaufman J, Birmaher B, Brent D, et al. (1997) Schedule for affective disorders and schizophrenia for school-age children present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988

    Article  PubMed  CAS  Google Scholar 

  31. Kelly TM, Cornelius JR, Clark DB (2004) Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug and Alcohol Depend 73:87–97

    Article  Google Scholar 

  32. Kessler RC (2004) The epidemiology of dual diagnosis. Biol Psychiatry 56:730–737

    Article  PubMed  Google Scholar 

  33. King RD, Gaines LS, Lambert EW, Summerfelt WT, Bickman L (2000) The co-occurrence of psychiatric and substance use diagnosis in adolescents in different service systems: frequency, recognistion, cost, and outcome. J Behav Health Serv Res 27:417–430

    Article  PubMed  CAS  Google Scholar 

  34. Kranzler HR, Tinsley JA (eds.) (2004) Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders. Marcel Dekker Inc., New York

    Google Scholar 

  35. Lucas CP, Zhang H, Fisher PW, et al. (2001) The DISC predictive scales (DPS): efficiently screening for diagnoses. J Am Acad Child adolesc Psychiatry 40:443–449

    Article  PubMed  CAS  Google Scholar 

  36. Martino S, Grilo CM, Fehon DC (2002) Development of the drug abuse Screening test for adolescents (DAST-A). Addict Behav 25:57–70

    Article  Google Scholar 

  37. McLellan AT, Meyers K (2004) Contemporary addiction treatment: a review of systems problems for adults and adolescents. Biol Psychiatry 56:764–770

    Article  PubMed  Google Scholar 

  38. Molina BSG, Bukstein OG, Lynch KG (2002) Attention-deficit/hyperactivity disorder and conduct disorder symptomatology in adolescents with alcohol use disorders. Psychol Addict Behav 16:161–164

    Article  PubMed  Google Scholar 

  39. Myers MG, Stewart DG, Brown SA (1998) Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. Am J Psychiatry 155:479–485

    PubMed  CAS  Google Scholar 

  40. Pandina RJ, Johnson V, Labouvie EW (1992) Affectivity: A central mechanism in the development of drug dependence. In: Glantz M, Pickens R (eds) Vulnerability to Drug Abuse. American Psychological Association, Washington, DC, pp 179–209

    Chapter  Google Scholar 

  41. Rassool GH (2002) Dual diagnosis. substance misuse and psychiatric disorders. Blackwell Science, Oxford

    Google Scholar 

  42. Renner JA, Jr. (2004) How to train residents to identify and treat dual diagnosis patients. Biol Psychiatry 56:810–816

    PubMed  Google Scholar 

  43. Robbins MS, Kumar S, Walker-Barnes C, et al. (2002) Ethnic differences in comorbidity among abusing adolescents referred to outpatient therapy. J Am Acad Child Adolesc Psychiatry 41:394–401

    Article  PubMed  Google Scholar 

  44. Roberts N, Vargo B, Ferguson HB (1989) Measurement of anxiety and depression in children and adolescents. Psychiatr Clin North Am 12:837–860

    PubMed  CAS  Google Scholar 

  45. Rowe CL, Liddle HA, Greenbaum PE, Henderson CE (2004) Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat 26:129–140

    Article  PubMed  Google Scholar 

  46. Rounds-Bryant JL, Kristiansen PL, Hubbard RL (1999) Drug abuse treatment outcome study of adolescents: a comparison of client characteristics and pretreatment behaviors in three treatment modalities. Am J Drug Alcohol Abuse 25:573–591

    Article  PubMed  CAS  Google Scholar 

  47. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME (2000) NIMH diagnostic interview schedule for children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28–38

    Article  PubMed  CAS  Google Scholar 

  48. Shaffer D, Fisher P, Dulcan M, et al. (1996) The NIMH diagnostic interview schedule for children version (DISC-2.3; description, acceptability, prevalence and performance in the MECA study). J Am Acad Child Adolesc psychiatry 35:865–877

    Article  PubMed  CAS  Google Scholar 

  49. Shaffer D, Schwab-Stone M, Fisher P, Cohen P, Piacentini J, Davies M, Conners CK, Regier D (1993) The Diagnostic Interview Schedule for Children-Revised Version (DISC-R): I. Preparation, field testing, interrater reliability, and acceptability. J Am Acad Child Adolesc Psychiatry 32:643–650

    PubMed  CAS  Google Scholar 

  50. Shrier LA, Harris SK, Kurland M, Knight JR (2003) Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics 111:e699–705

    Article  PubMed  Google Scholar 

  51. Spitzer R, Williams J, gibbon B (1987) Instruction manual for the structured clinical interview for DSM-III-R. State Psychiatric Institute, New York

    Google Scholar 

  52. Slaats-Willemse D, Swaab-Barneveld H, de Sonneville L, van der Meulen E, Buitelaar J (2003) Deficient response inhibition as a cognitive endophenotype of ADHD. J Am Acad Child Adolesc Psychiatry 42:1242–1248

    Article  PubMed  Google Scholar 

  53. Tarter RE, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M, Gardner W, Blackson T, Clark D (2003) Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Drug Alcohol Dep 73:121–132

    Article  Google Scholar 

  54. Tarter R, Kirisci L, Mezzich A (1997) Multivariate typology of adolescents with alcohol use disorder. Am J Addic 6:150–158. Am J Psychiatry 160:1078–1085

    Article  Google Scholar 

  55. Tims FM, Dennis ML, Hamilton N (2002) Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction 97:46–57

    Article  PubMed  Google Scholar 

  56. Tomlinson KL, Brown SA, Abrantes A (2004) Psychiatric comorbidity and substance use treatment outcomes of adolescents. Psychol Addict Behav 18:160–169

    Article  PubMed  Google Scholar 

  57. Verhulst FC (2002) Inleiding in de kinder- en jeugdpsychiatrie. Koninklijke Van Gorcum b.v., Assen

    Google Scholar 

  58. Vreugdenhil C, Van Den Brink W, Wouters LF, Doreleijers TA (2003) Substance use, substance use disorders, and comorbidity patterns in a representative sample of incarcerated male Dutch adolescents. J Nerv Ment Dis 91:372–378

    Article  Google Scholar 

  59. Weissman MM, Wolk S, Wickramaratne P, Goldstein RB, Adams P, Greenwald S, et al. (1999) Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry 56:794–801

    Article  PubMed  CAS  Google Scholar 

  60. White H, Xie M, Thompson W (2001) Psychopathology as a predictor of adolescent drug use trajectories. Psychol Addict Behav 15:210–218

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the Stichting Kinder- & Jeugdpsychiatrie Oost-Nederland (SKJPON) for their generous support and the National Fund Mental Public Health (NFGV) for their grant (no. 5942).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christianne Couwenbergh MSc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Couwenbergh, C., van den Brink, W., Zwart, K. et al. Comorbid psychopathology in adolescents and young adults treated for substance use disorders. Eur Child Adolesc Psychiatry 15, 319–328 (2006). https://doi.org/10.1007/s00787-006-0535-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-006-0535-6

Keywords

Navigation